A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs - The New York Times
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs The New York Times FDA approves landmark pancreatic cancer drug that's shown to improve survival wusa9.com Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests ABC News - Breaking News, Latest News and Videos RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer BioSpace Newly approved pancreatic cancer drug shows promise in lung cancer NBC News source https://news.google.com/rss/articles/CBMihAFBVV95cUxOQ0RnU0xxUi04VnoyUThTcnRlVURaX3FXcjNEM3ZGN3F6RzI0OS1UbXg1SllQVGJBeUNmRGxMaklNbXZOX2FQZk5RRHNZeVkwalRPM0tRQjhjQ1dIMTk1eDFuYU94NHVfMnlFOGhSa2llbnlISUpTV2plbUkxZDJ0eERQeEs?oc=5